Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern India

17 Jul 2013

Abstract excerpt

BACKGROUND: Artesunate + sulphadoxine-pyrimethamine (AS + SP) is recommended throughout India as the first-line treatment for uncomplicated falciparum malaria. Due to the presence of several eco-epidemiological zones of malaria and variable drug pressure, it is necessary to evaluate the efficacy of this combination in different regions of India. The objective of this study was to use clinical and molecular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biological Research and Disease Studies
Share to Malaria Research and Control

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23866298
DOI: 10.1186/1475-2875-12-247

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A clinical and molecular study of artesunate + sulphadoxine-pyrimethamine in three districts of central and eastern IndiaPMID 23866298Read ↗

Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014.Semantic proximity Read ↗

Polymorphisms in pfdhfr and pfdhps genes after five years of artemisinin combination therapy (ACT) implementation from urban Kolkata, India.Semantic proximity Read ↗

Efficacy of artemisinin-based combination therapies for the treatment of falciparum malaria in Pakistan (2007-2015): In vivo response and dhfr and dhps mutations.Semantic proximity Read ↗

Plasmodium falciparum isolates in India exhibit a progressive increase in mutations associated with sulfadoxine-pyrimethamine resistance.Semantic proximity Read ↗

Antifolate drug resistance: Novel mutations and haplotype distribution in dhps and dhfr from Northeast India.Semantic proximity Read ↗

Genetic profiling of sulfadoxine-pyrimethamine resistance markers in Indian Plasmodium falciparum field isolates.Semantic proximity Read ↗

Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, IndiaSemantic proximity Read ↗

Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.Semantic proximity Read ↗

Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam.Semantic proximity Read ↗

Genomic characterization of Plasmodium falciparum genes associated with anti-folate drug resistance and treatment outcomes in eastern India: A molecular surveillance study from 2008 to 2017.Semantic proximity Read ↗

Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, IndiaSemantic proximity Read ↗

Molecular epidemiology of Plasmodium vivax anti-folate resistance in India.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.